AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

Shawn Kortes, known for his philanthropic work in the community, started dialysis this year and is searching for a kidney ...

Northern Scotland has one of the highest rates of Huntington's disease in the world, according to a new study. Huntington's ...

Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people ...

"Pridopidine shows long-term sustained efficacy up to 2 years, and there's significant long-term benefit confirmed compared to a matched cohort in ENROLL-HD and in TRACK-HD," both observational cohort ...

But what exactly is ALS and what does it do to the body? Here's everything you need to know. Amyotrophic lateral sclerosis (ALS) is a progressive terminal disease that affects "what are essentially ...

A major health alert has been issued for anyone who has visited a major city in the last 10 days after several cases of a potentially life-threatening disease were confirmed. Over the past three ...

Parkinson’s disease is a chronic neurological disorder that mainly affects movement, but it can also impact speech, mood, sleep, and even memory. While medications help manage symptoms ...

Pridopidine showed promise in patients with Huntington’s disease who were not on antidopaminergic medications. The safety and tolerability of pridopidine was comparable to placebo. SAN DIEGO ...

Fox Foundation for Parkinson’s research. “We know a lot of people that have fought this disease and are still fighting this disease, so that’s the No. 1 goal there,” Manis told 11 News.